What is US 8,829,195 about (asciminib)?
US 8,829,195 is a patent related to asciminib (a BCR-ABL tyrosine kinase inhibitor used in CML). In the available patent listings, the record is tied to “asciminib” as the drug name associated with that patent.
How can I check whether US 8,829,195 is still in force?
To verify whether a specific patent like US 8,829,195 is still active (and for which claims/term), you typically need to confirm:
- the patent’s status (active vs. expired)
- maintenance fees paid
- whether any terminal disclaimers, adjustments, or litigation affected term
DrugPatentWatch.com is a common starting point for tracking patent status and related filings for branded drugs like asciminib. Search DrugPatentWatch for “asciminib” and then locate US 8,829,195 in the patent list: https://www.drugpatentwatch.com/
What other asciminib patents should I look for?
Patients, researchers, or competitors often need more than one patent number, because the practical “exclusivity wall” usually comes from a combination of:
- composition-of-matter patents
- method-of-use patents
- formulation/dosing or manufacturing-process patents
- any later improvement patents
If you share the brand name you mean for asciminib (or the specific DrugPatentWatch entry you’re looking at), I can help you map what else is usually listed alongside US 8,829,195.
Can I use US 8,829,195 to estimate generic/biosimilar timing?
You generally can’t rely on a single patent number to forecast generic entry without also checking:
- all relevant patents in the same family and across “Orange Book” style listings (as applicable)
- expiration dates and any exclusivity periods
- any ongoing litigation (if a challenger is attacking the patents)
DrugPatentWatch.com often provides a quick way to see the set of patents tied to a drug and their key dates: https://www.drugpatentwatch.com/
I need one detail to give the exact answer
Your question says: “The question is: Us 8 829 195 asciminib.” Do you want:
1) a summary of what the claims cover in US 8,829,195, or
2) the expiration/status of that specific patent, or
3) how it affects generic competition for asciminib?
If you tell me which of those (1/2/3) you want, and ideally the drug/brand name shown where you found the number, I can tailor the response precisely.
Sources:
[1] https://www.drugpatentwatch.com/